The ‘absolutely stellar’ team at Clifford Chance LLP acts for a varied client list of medical device, healthcare, and biotech companies in matters concerning reimbursement, market access, and licensing. Practice co-head Stephen Reese handles both contentious and non-contentious IP issues, including the exploitation and enforcement of rights, and R&D agreements. Co-head Gareth Camp maintains a corporate focused practice, often assisting clients with public bids, joint ventures, and group restructurings. Noted by clients for his ‘formidable knowledge and skill set’, Luke Tolaini primarily advises generics companies on excessive pricing investigations, in addition to appeals concerning CMA decisions, supported by ‘fantastic’ senior associate Ben Jasper.
Testimonials
Collated independently by Legal 500 research team.
‘Clifford Chance's Healthcare & Life Science's team is absolutely stellar. It is second to none in terms of the depth of its knowledge and has the extraordinary advantage of being able to cover absolutely every aspect of a case for its clients, no matter what the issue that arises. Clifford Chance is a one-stop-shop like no other in London; and that is invaluable.’
‘Luke Tolaini is absolutely superb. He is a delight to work with and wears his formidable knowledge and skill set lightly and with elegance. Absolutely the sort of fantastic solicitor one wants on one's side in a dispute.'
- 'Ben Jasper is wonderful. He cuts to the chase, identifies the important points, fights hard and delivers for his client. He is also a delight to work with, being collaborative, supportive, informed and available. He really is fantastic.'
- 'The litigation team are very experienced in defending these types of cases and work very well with specialist advisory lawyers.’
‘Luke Tolaini is a great lawyer with a great feel for what points really matter, how things will play out, and how to deal with very demanding high stakes cases.'
- 'Ben Jasper is an up and coming star of the litigation team, meticulous, can always be relied upon to have gone the extra mile, and always a complete pleasure to deal with even in the midst of very demanding stressful cases.'
Key clients
- Her Majesty's Government
- Department for Business, Energy and Industrial Strategy
- Cinven
- Pfizer
- Gilead Sciences
- Informa
- NorthWest Healthcare Properties REIT
- Ultrahuman Healthcare Private Limited
- Oracle Corporation
- MedAccess
- Fujifilm Kyowa Kirin Biologics
Work highlights
- Advised Pfizer Inc. on its acquisition of ReViral Limited.
- Advising HMG as part of its collaboration with Moderna to procure the development, manufacturing and supply of mRNA vaccines and therapeutics to the UK population for the treatment of COVID-19 and other respiratory diseases (including influenza and respiratory syncytial virus).
- Advising Cinven on three separate high-profile appeals before the CAT against CMA Decisions for the alleged antitrust infringements of a former portfolio company active in generic pharmaceuticals, now named Advanz. The firm also advised on a fourth investigation in relation to an alleged market sharing arrangement for the supply of 50mg and 100mg nitrofurantoin capsules, which the CMA closed.
Lawyers
Practice head
The lawyer(s) leading their teams.
Stephen Reese, Gareth Camp